Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rusyn, I.
Right arrow Articles by Thurman, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rusyn, I.
Right arrow Articles by Thurman, R. G.
[Cancer Research 60, 4798-4803, September 1, 2000]
© 2000 American Association for Cancer Research


Carcinogenesis

Oxidants from Nicotinamide Adenine Dinucleotide Phosphate Oxidase Are Involved in Triggering Cell Proliferation in the Liver Due to Peroxisome Proliferators1

Ivan Rusyn, Shunhei Yamashina, Brahm H. Segal, Robert Schoonhoven, Steven M. Holland, Russell C. Cattley, James A. Swenberg and Ronald G. Thurman2

Laboratory of Hepatobiology and Toxicology, Department of Pharmacology [I. R., S. Y., R. G. T.], Curriculum in Toxicology [I. R., J. A. S., R. G. T.], and Department of Environmental Sciences and Engineering [R. S., J. A. S.], University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599; Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland 20892 [B. H. S., S. M. H.]; and Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina 27709 [R. C. C.].


    ABSTRACT
 Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
It was shown that 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio acetic acid (Wy-14,643), a potent peroxisome proliferator, caused rapid oxidant-dependent activation of nuclear factor {kappa}B (NF-{kappa}B) in Kupffer cells in vivo and activated superoxide production by isolated Kupffer cells. Here, we tested the hypothesis that NADPH oxidase (NADPH OX) is the source of oxidants increased by Wy-14,643. Indeed, both activation of NF-{kappa}B and increases in cell proliferation due to a single dose of Wy-14,643 (100 mg/kg) were prevented completely when rats were pretreated with diphenyleneiodonium (1 mg/kg), an inhibitor of NADPH OX. p47phox is a critical subunit of NADPH OX; therefore, p47phox knockout mice were used to specifically address the hypothesis of NADPH OX involvement. In livers of wild-type mice, Wy-14,643 activated NF-{kappa}B, followed by an increase in mRNA for tumor necrosis factor {alpha}. Importantly, these changes did not occur in p47phox knockouts. Moreover, when Kupffer cells were treated with Wy-14,643 in vitro, superoxide production was increased in cells from wild-type but not p47phox-null mice. Finally, when mice were fed a Wy-14,643-containing (0.1%) diet for 7 days, the increase in liver weight and cell proliferation caused by Wy-14,643 in wild-type mice was blocked in p47phox-null mice. Combined, these results are consistent with the hypothesis that Wy-14,643 activates NADPH OX, which leads to NF-{kappa}B-mediated production of mitogens that causes hepatocellular proliferation characteristic of this class of nongenotoxic carcinogens.


    INTRODUCTION
 Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
Peroxisome proliferators are a broad group of nongenotoxic carcinogens including both synthetic and naturally occurring compounds, such as hypolipidemic drugs, phthalate esters, industrial solvents, herbicides, some steroids, and food flavors. These agents, administered to rodents, cause hepatomegaly, proliferation of peroxisomes in hepatic parenchymal cells, and marked increases in the activities of enzymes required for peroxisomal ß-oxidation of fatty acids (1) . Two mechanisms have been proposed for peroxisome proliferator-induced hepatocarcinogenesis: (a) increased cell proliferation and promotion of spontaneously initiated lesions; and (b) oxidative stress, resulting from a disproportionate increase in production of oxidants. However, recent observations that oxidant-dependent NF-{kappa}B3 activation in Kupffer cells plays a critical role in increased hepatocyte proliferation caused by Wy-14,643 (2) and ciprofibrate (3) suggest that these mechanisms may not be mutually exclusive (i.e., that oxidants could play a role in signaling production of mitogens in specialized cells in the liver).

Cell proliferation has been linked experimentally and conceptually to carcinogenesis induced by both genotoxic and nongenotoxic carcinogens as a crucial event in converting DNA damage to heritable mutations and causing clonal expansion of mutated cell populations (4) . Increased proliferation of hepatocytes observed during continued treatment with peroxisome proliferators is thought to contribute to the carcinogenic process. Indeed, it was found that sustained increases in cell proliferation correlated with tumor number (5) . The idea that spontaneously initiated cells are promoted by this class of compounds was supported by the observation that more tumors develop in older than in younger rats fed nafenopin or Wy-14,643, although tumors were found in both of these groups (6 , 7) . Furthermore, these chemicals induce preferential growth of altered hepatocytes in preneoplastic foci (8) .

It was recently suggested that low levels of oxidants may play a role in signaling increases in cell proliferation caused by peroxisome proliferators via a Kupffer cell-mediated mechanism involving TNF{alpha} and NF-{kappa}B (9) . Indeed, hepatocyte proliferation caused by Wy-14,643 was prevented by inactivation of Kupffer cell production of TNF{alpha} with methyl palmitate (10) , antibodies to TNF{alpha} (11) , or dietary glycine (12) . Furthermore, activation of NF-{kappa}B by Wy-14,643 occurs rapidly in Kupffer cells and precedes changes in hepatocytes (2) . Moreover, Wy-14,643 caused superoxide anion production in isolated Kupffer cells (13) . Oxidants are known to play a major role in the activation of NF-{kappa}B. Indeed, pretreatment of rats with allopurinol, a free radical scavenger (14) , abolished Wy-14,643-induced activation of NF-{kappa}B (2) . Furthermore, when catalase was overexpressed in mouse liver, the activation of NF-{kappa}B and increase in cell proliferation caused by treatment with the peroxisome proliferator ciprofibrate was decreased significantly (3) .

Collectively, these observations support the concept that oxidants play a significant role in the peroxisome proliferator-induced proliferative response. Because it is unclear how peroxisome proliferators increase production of reactive oxygen species, these studies were designed to determine whether NADPH OX, a major superoxide-producing enzyme in macrophages, is involved in the oxidant-dependent activation of NF-{kappa}B by the peroxisome proliferator Wy-14,643 in Kupffer cells.


    MATERIALS AND METHODS
 Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
Animals and Treatments.
Female Sprague Dawley rats (body weight, 175–225 g) and C57BL/6 x sv129 wild-type and p47phox knockout mice (body weight, 25–30 g) were used in these experiments. NADPH OX-deficient mice (p47phox-/-) were created by targeted disruption of p47phox, a critical cytosolic component of NADPH OX (15) . Rats were housed three to four per cage with a 12-h day/night cycle and given laboratory chow and water ad libitum. Animals were acclimated for 1 week before treatment, and Institutional Animal Care and Use Committee criteria were followed. Mice were housed four per cage in biologically clean rooms with filtered air and sterilized feed and water. Wy-14,643 was obtained from Chemsyn Science Laboratories (Lenexa, KS), and DPI was purchased from Toronto Research Chemicals (Toronto, Ontario). All other chemicals and reagents were of the highest available purity from standard suppliers. Animals were given a single dose of Wy-14,643 (100 mg/kg) in olive oil vehicle, whereas control animals received equal amounts of vehicle (1.5 ml/kg). Animals were sacrificed under pentobarbital anesthesia at different time intervals ranging from 1 h to 7 days. In some experiments, rats were pretreated with DPI (1 mg/kg s.c.) for 4 days before Wy-14,643 administration. To assess rates of cell proliferation in response to Wy-14,643 in p47phox (+/+) or (-/-) mice, animals were given dietary Wy-14,643 (0.1% w/w) for 7 days.

Preparation of Nuclear Extracts and Electrophoretic Mobility Shift Assays.
Nuclear protein extracts were prepared on ice as described by Dignam et al. (16) with minor modifications (2) . Protein concentration was determined using the Bradford protein concentration assay kit (Bio-Rad, Hercules, CA; Ref. 17 ). A gel mobility shift assay was used in this study to assess the amount of active protein involved in protein-DNA interactions. Binding conditions for NF-{kappa}B were characterized, and electrophoretic mobility shift assays were performed as described in detail elsewhere (18) . Briefly, equal amounts (40 µg) of nuclear extract were preincubated 10 min on ice with 1 µg of poly (dI-dC) and 20 µg of BSA (both from Pharmacia Biotech, Piscataway, NJ) and 2 µl of a 32P-labeled DNA probe (10,000 cpm/µl; Cerenkov) containing 1 ng of double-stranded oligonucleotide in a total volume of 20 µl. Mixtures were incubated 20 min on ice and resolved on 5% polyacrylamide (29:1 cross-linking) and 0.4x Tris-borate EDTA gels. After electrophoresis, gels were dried and exposed to Kodak film. In supershift experiments, 1 µl of rabbit antisera against p50 and p65 protein (a kind gift from Dr. N. R. Rice, National Cancer Institute, Bethesda, MD) was added to the reaction mixture after incubation with a labeled probe that was further incubated at 25°C for 30 min. Labeled and unlabeled oligonucleotides contained the consensus sequence for NF-{kappa}B (19) . Data were quantitated by scanning autoradiograms with GelScan XL (Pharmacia LKB, Uppsala, Sweden).

Isolation of RNA and RNase Protection Assay.
Samples of liver tissue were homogenized in 2 ml of RNAzol B solution, and total cellular RNA was extracted according to standard procedures (20) . RNA was dissolved in Tris-EDTA buffer [10 mM Tris-HCl and 1 mM EDTA (pH 8.0)]. Rodent cytokine multinucleotide RNA probe template sets (rCK-1 for rat tissue and mCK-3b for mouse tissue; PharMingen, San Diego, CA) were used for synthesis of radiolabeled ([32P]UTP) antisense RNA probes, and RNase protection assays were performed on 30 µg of individual liver RNA samples using a RiboQuant multiprobe RNase Protection assay kit (PharMingen). Protected fragments were separated on 6% polyacrylamide QuickPoint (NOVEX, San Diego, CA) gels, dried, and exposed to X-ray film. Intensities of protected bands were quantified using an image analyzer.

Superoxide Production by Kupffer Cells.
Rat and mouse livers were perfused as described elsewhere (21) , and the nonparenchymal cell fractions were separated by centrifugation through Percoll gradients based on the method of Smedsrod and Pertoft (22) . Nonparenchymal cells were seeded at a density of 106 cells/well in 24-well plates and cultured in RPMI 1640 containing low glucose and 10% fatty acid-free BSA. After 1 h, nonadherent cells were removed by replacing the culture media and adherent cells were verified to be Kupffer cells by phagocytosis of FITC-labeled latex beads (1 µm diameter; Polysciences, Warrington, PA) by fluorescent microscopy (23) . Cells were cultured for 24 h prior to all experiments. Subsequently, media was removed and Kupffer cells were washed twice with HBSS. Wy-14,643 (10 µM) was added to cells and incubated in HBSS at 37°C. After 30 min, cytochrome c (50 µM) was added to each well and the reaction was allowed to proceed for an additional 30 min at 37°C. Superoxide generation was assessed as reduction of cytochrome c inhibitable by superoxide dismutase, as described elsewhere (13) .

Cell Proliferation.
Rats were given BrdUrd (100 mg/kg i.p.; Sigma Chemical Co.) 1 h before sacrifice. In experiments with mice, cell proliferation was assessed with osmotic pumps (Alzet model 2001, 1 µl/hr; Alza Corp., Palo Alto, CA), which were implanted s.c. and contained 200 µl of 16 mg/ml BrdUrd. After sacrifice, livers were rinsed with HBSS and fixed with 4% paraformaldehyde for subsequent paraffin embedding. A section of duodenum, a tissue that proliferates rapidly, was collected as a positive control for BrdUrd incorporation. Tissue sections (5 µm) were deparaffinized, rehydrated, and hydrolyzed in 4 N HCl for 20 min at 37°C. Immunohistochemical staining was performed using a DAKO Envision System Peroxidase Staining Kit (DAKO, Carpinteria, CA) and a primary monoclonal antibody to BrdUrd (clone Bu20a; DAKO), as described elsewhere (12) . Cel1 proliferation was quantitated by determining the percentage of BrdUrd-positive hepatocytes in 10 random high-power fields/slide (1000 hepatocytes/slide).

Acyl-CoA Activity.
Acyl-CoA oxidase is localized in peroxisomes, and its activity, measured as formaldehyde formed from hydrogen peroxide generated by peroxisomal ß-oxidation, is a measure of induction of peroxisomes (24) . Liver samples (~100 µg) were homogenized in 10 volumes of 0.25 M sucrose buffer. A reaction mixture (1.4 ml; for details see Ref. 12 ) was warmed to 37°C and mixed with 200 µl of homogenate. The reaction was terminated after 10 min with 40% trichloracetic acid. Trichloracetic acid was added before homogenate to the blanks. The solution was centrifuged to pellet protein, and 0.5 ml of supernatant was added to 0.2 ml of Nash Reagent to measure formaldehyde (25) . After 60 min of incubation at 37°C, absorbance was read at 405 nm. Protein concentration was determined by the method of Bradford (17) .

Statistics.
Results are reported as means ± SEM with n = 4 to 5 in each group. Treatment groups were compared using one-way ANOVA, followed by Student-Neuman-Keuls post-hoc test, or two-way ANOVA using Student-Neuman-Keuls post-hoc test, where appropriate. A P < 0.05 was selected before the study to determine statistical differences between groups.


    RESULTS AND DISCUSSION
 Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
Early Effects of the Peroxisome Proliferator Wy-14,643 on NF-{kappa}B, TNF{alpha}, and Cell Proliferation in Rat Liver Are Blocked by Inhibiting Generation of Superoxide.
It was recently shown that rapid activation of NF-{kappa}B in Kupffer cells from rats treated with the peroxisome proliferator Wy-14,643 was free radical dependent because it was blocked by the radical scavenger allopurinol (2) . Because NADPH OX is a major source of reactive oxygen species in activated macrophages, such as Kupffer cells, DPI, an inhibitor of the NADPH OX (26) , was used to test the hypothesis that reactive oxygen species are involved in peroxisome proliferator-induced stimulation of growth of parenchymal cells. Rats were pretreated with DPI (1 mg/kg/day s.c.) for 4 days before administration of Wy-14,643 [100 mg/kg intradermally (i.g.)]. The dose of DPI and route of administration were selected based on: (a) the IC50 value of 6 mg/kg for rat (27) ; and (b) the proven pharmacological effectiveness of DPI in a long-term study in rats (28) .

In a whole liver, Wy-14,643 causes a ~3.5-fold increase in NF-{kappa}B activity as early as 2 h after treatment (2 ; Fig. 1Citation ). This activation was blocked completely by pretreatment with DPI (Fig. 1)Citation . Similarly, WY-14,643 increased TNF{alpha} mRNA about 2-fold, which is regulated by NF-{kappa}B, an effect also prevented by DPI (data not shown). It is known that NF-{kappa}B is activated by peroxisome proliferators first in Kupffer cells (2) . Moreover, Kupffer cells are the main source of TNF{alpha} in the liver (29) , and TNF{alpha} is a direct hepatocyte mitogen (30) . To test whether Kupffer cell NADPH OX is inhibited by DPI, Kupffer cells were isolated from untreated rats and cultured in the presence or absence of DPI (15 µM). LPS (100 ng/ml), a known activator of NADPH OX in macrophages, was added. Indeed, LPS increased superoxide anion production by Kupffer cells by ~5.5-fold (control, 0.4 ± 0.2 nmol/106 cells/15 min; LPS, 2.2 ± 0.2 nmol/106 cells/15 min), and DPI blocked this increase completely (0.2 ± 0.1 nmol/106 cells/15 min). Therefore, it is concluded that DPI blocks superoxide-generating capacity of Kupffer cells by inhibiting NADPH OX (see below).



View larger version (31K):
[in this window]
[in a new window]
 
Fig. 1. DPI prevents rapid activation of NF-{kappa}B in liver by Wy-14,643. Rats were given either 5% glucose s.c. (CON and WY) or DPI (1 mg/kg, s.c.; DPI and WY+DPI) for 4 days and sacrificed 2 h after a single dose of Wy-14,643 (100 mg/kg) or olive oil vehicle. Activity of NF-{kappa}B was assessed using electrophoretic mobility shift assays as detailed in "Materials and Methods." Density of the NF-{kappa}B/DNA complex images of control rats (CON, 5% glucose and olive oil treated) were not different, and, therefore, set to 100%. Data are mean ± SEM (n = 4). The statistical differences of Wy-14,643-treated animals (WY) from control (a) and Wy-14,643 + DPI-treated animals (WY+DPI) from WY (b) groups (P < 0.05), respectively, are by two-way ANOVA using Student-Newman-Keul’s post-hoc test.

 
Kupffer cell oxidants, NF-{kappa}B, and TNF{alpha} have been suggested as the signaling pathway activated by peroxisome proliferators in rodent liver, which leads to increased hepatocellular proliferation (9 , 31) . Indeed, when cell proliferation was assessed 24 h after gavage with Wy-14,643, a 5-fold increase in DNA synthesis caused by WY-14,643 was prevented by DPI (Fig. 2ACitation , WY and WY+DPI). Treatments with olive oil, a vehicle for Wy-14,643, and 5% glucose, a vehicle for DPI, or DPI alone had no effect on either cell proliferation (CON and DPI, respectively) or activity of NF-{kappa}B (data not shown). Importantly, a 3-fold induction of peroxisomes, which was assessed by measuring activity of the marker enzyme of peroxisomal proliferation, acyl-CoA-oxidase, was not affected by DPI (Fig. 2B)Citation . These results support the hypothesis (5 , 31) that up-regulation of peroxisomal enzymes occurs independently of activation of proliferation of hepatocytes.



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2. DPI blocks increases in hepatocyte proliferation but not induction of peroxisomes in rat liver after treatment with Wy-14,643. Rats were treated with Wy-14,643 (100 mg/kg; WY) or olive oil vehicle (0.4 ml; CON) for 24 h and injected with BrdUrd (100 mg/kg) 1 h before sacrifice. Some animals were given DPI (1 mg/kg s.c.) for 4 days before other treatments. A, rates of hepatocyte proliferation in rat liver were determined immunohistochemically. B, activity of acyl-CoA oxidase was assessed as detailed in "Materials and Methods." Results are reported as mean ± SEM (n = 4 in each group). The statistical differences (P < 0.05) from control (a) or Wy-14,643-treated (b) groups are by two-way ANOVA, followed by Student-Newman-Keul’s post-hoc test.

 
The use of pharmacological inhibitors, such as DPI, yields valuable mechanistic information; however, it may lack selectivity, making unequivocal interpretation difficult. To avoid such possible difficulties, a recently developed mouse NADPH OX-deficient knockout model was used (15) .

NADPH OX Is the Molecular Source of Oxidants Produced by Kupffer Cells Due to Peroxisome Proliferators.
Peroxisomal ß-oxidation of fatty acids is unique because it produces H2O2 instead of NADH; therefore, it was initially thought that these compounds caused oxidative stress leading to oxidized DNA bases (32) . Despite the fact that oxidized bases have been detected (33) , this idea has been challenged (34) . First, several studies failed to detect DNA adducts or modified DNA bases after chronic exposure to plasticizers or other peroxisome proliferators (35) . Furthermore, given the extremely high rate at which peroxisomal catalase converts H2O2 into H2O, H2O2 should not escape peroxisomes (36) . In fact, it was shown that treatment with ciprofibrate and perfluorooctanoate increased H2O2 in vitro but not in the perfused liver where fatty acid supply is rate limiting for H2O2 generation via peroxisomal ß-oxidation (37) . Moreover, spontaneous liver tumors occur in mice lacking peroxisomal fatty acyl-CoA oxidase (38) . On the other hand, recent evidence that reactive oxygen species are produced by Kupffer cells and are involved in triggering cell proliferation suggests a new role for oxidants in the molecular mechanism of peroxisome proliferators.

To specifically address the question of whether NADPH OX is the molecular source of oxidants produced due to Wy-14,643, knockout mice that lack the p47phox component of this enzyme were used (15) . First, p47phox-null (-/-) and wild-type (+/+) mice were gavaged with Wy-14,643 (100 mg/kg) for different times up to 24 h, and NF-{kappa}B activity was assessed in whole liver nuclear extracts (Fig. 3)Citation . The activation of NF-{kappa}B in liver of wild-type mice was time dependent with a peak at 5–8 h (~2-fold) after Wy-14,643 administration, followed by a steady decline toward basal levels. However, no activation of NF-{kappa}B was observed in p47phox (-/-) mice. Similarly, a significant increase in activity of NF-{kappa}B was observed in liver of wild-type mice given Wy-14,643 for 5 h; however, no changes were detected in knockout mice (data not shown). Furthermore, mRNA for TNF{alpha} increased in a time-dependent manner and was nearly 3-fold greater after treatment with Wy-14,643 in p47phox (+/+) mice in 24 h (Fig. 4)Citation . Importantly, Wy-14,643 failed to up-regulate TNF{alpha} mRNA levels in p47phox (-/-) mice.



View larger version (34K):
[in this window]
[in a new window]
 
Fig. 3. Wy-14,643 does not activate NF-{kappa}B in liver of NADPH OX knockout mice. A, mice deficient in the NADPH OX regulatory subunit p47phox (KO) and wild-type counterparts (WT) were treated with a single dose of Wy-14,643 (100 mg/kg) and killed at the time points shown. Nuclear extracts from whole liver (40 µg of protein in each lane) were incubated with 32P-labeled double-stranded oligonocleotide encompassing the {kappa}B motif. B, data shown are results of densitometric analysis of the NF-{kappa}B/DNA complex images. Density of the NF-{kappa}B/DNA complex in livers of untreated mice was set to 100%. Treatment with vehicle only had no significant effect on NF-{kappa}B activity. Data are reported as mean ± SEM from three to four separate experiments. *, statistical differences from control group (P < 0.05) by one-way ANOVA using Student-Newman-Keul’s post-hoc test. C, protein binding to a labeled oligonucleotide probe is specific for the active form of NF-{kappa}B. Lane 1, labeled probe with no nuclear extract present; Lanes 2-7, nuclear extracts from wild-type (Lanes 2, 4, and 6) or p47phox (Lanes 3, 5, and 7) mice killed 5 h after a single dose of Wy-14,643 (100 mg/kg) incubated with labeled probe with no further additions (Lanes 2 and 3) or in the presence of 1 µl of rabbit antisera against p50 (Lanes 4 and 5), or p65 (Lanes 6 and 7) subunits of NF-{kappa}B. The positions of native (open arrow) and supershifted (filled arrows) complexes are shown.

 


View larger version (52K):
[in this window]
[in a new window]
 
Fig. 4. Wy-14,643 increases TNF{alpha} mRNA in livers of wild-type but not NADPH OX knockout mice. Mice were treated with Wy-14,643, as detailed above, and sacrificed at the time points shown. TNF{alpha}, L32, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNAs were assayed by RNase protection assay using a mouse cytokine template set, as detailed in "Materials and Methods." Representative autoradiogram from three separate experiments.

 
Furthermore, to test whether Kupffer cells from p47phox-null mice could be activated by Wy-14,643 in vitro, cells were isolated, cultured, and treated with Wy-14,643 (10 µM). Previously, it was reported that p47phox (-/-) phagocytes do not respond to phorbol 12-myristate 13-acetate treatment with a respiratory burst (15) . In this study, both LPS, a potent activator of Kupffer cells, and Wy-14,643, an agent known to activate Kupffer cells from rats (13) and mice (39) , increased superoxide generation significantly in Kupffer cells from p47phox(+/+), but not p47phox-null mice (Fig. 5)Citation .



View larger version (22K):
[in this window]
[in a new window]
 
Fig. 5. Superoxide production by Kupffer cells from wild-type and p47phox-null mice. Kupffer cells were isolated from either wild-type ({blacksquare}) or p47phox-null ({square}) mice and seeded at a density of 106 cells/ml in 24-well plates. To measure superoxide, Kupffer cells were incubated in HBSS (CON) with either 10 µg/ml LPS, 10 µM Wy-14,643 (WY), or vehicle control (VEH; DMSO, 0.1% final concentration) and cultured for 30 min at 37°C. Superoxide was determined as reduction of cytochrome c inhibitable by superoxide dismutase, as described in "Materials and Methods." Data are presented as means ± SE. a, statistical differences (P < 0.05) from control group by two-way ANOVA, followed by Student-Newman-Keul’s post-hoc test (n = 4 preparations in each group).

 
Finally, to determine whether blocking superoxide-induced signaling in Kupffer cells would affect the rapid increase in hepatocellular proliferation due to Wy-14,643, wild-type and p47phox-null mice were fed control (NIH-07) or Wy-14,643-containing (0.1% w/w) diets for 7 days. As expected, in the wild-type mice fed the Wy-14,643 diet, mean relative liver weight (percentage of body weight) was increased significantly compared with wild-type control mice (Fig. 6A)Citation . Importantly, this increase in relative mean liver weight due to Wy-14,643 administration did not occur in p47phox (-/-) mice (Fig. 6A)Citation . Moreover, the increase in liver weight in wild-type mice fed a Wy-14,643 diet was accompanied by a significant 6-fold increase in BrdUrd labeling index compared with wild-type controls (Fig. 6B)Citation . However, hepatocellular BrdUrd labeling index was not increased by Wy-14,643 in p47phox (-/-) mice. In contrast, acyl-CoA oxidase was increased equally in livers of wild-type and knockout mice treated with Wy-14,643 for either 24 h (data not shown) or 7 days (Fig. 6C)Citation .



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6. Liver weight, hepatocyte proliferation, and induction of peroxisomes in wild-type and p47phox knockout mice fed Wy-14,643 for 7 days. Wild-type or p47phox knockout mice were fed powdered NIH-07 diet with or without Wy-14,643 (0.1% w/w) for 1 week. Livers were collected at sacrifice, weighed, and processed for BrdUrd immunohistochemistry or acyl-CoA oxidase activity, as detailed in "Materials and Methods." Values are mean ± SEM. a and b represent the statistical difference (P < 0.05) between animals on the NIH-07 diet or wild-type mice fed Wy-14,643 (WY), respectively, by two-way ANOVA using Student-Newman-Keul’s post-hoc test.

 
Oxidants from Kupffer Cells Play a Central Role in the Mechanism of Proliferative Effects Induced by Wy-14,643.
It is hypothesized that peroxisome proliferators, such as Wy-14,643, activate Kupffer cells that produce TNF{alpha}, thus triggering hepatocyte proliferation (see Fig. 7Citation ). Moreover, evidence that Kupffer cells are involved in the mechanism of action of phthalates has also been presented (9) . In this study, it was demonstrated that Kupffer cell NADPH OX is activated leading to production of superoxide (O2·-), which activates nuclear factor NF-{kappa}B, a transcription factor that regulates TNF{alpha} production; however, it is not clear how Wy-14,643 activates NADPH OX. Phosphorylation of p47phox and other proteins that comprise this multiunit oxidant-producing enzyme leads to the assembly of the complex on the membrane and production of superoxide anion (40) . It is hypothesized that peroxisome proliferators activate NADPH OX via PKC, an enzyme involved in increased cell proliferation and tumor promotion (41) . Indeed, PKC is known to activate NADPH OX in macrophages via phosphorylation of p47phox, a regulatory subunit of this enzyme (42) . Recently, convincing evidence for activation of PKC in Kupffer cells by peroxisome proliferators has been presented (13) .



View larger version (29K):
[in this window]
[in a new window]
 
Fig. 7. Working hypothesis for involvement of NADPH OX in activation of NF-{kappa}B by Wy-14,643. It is hypothesized that Kupffer cells NADPH OX are activated by Wy-14,643 to produce superoxide anion. This activates the transcription factor NF-{kappa}B, triggers production of TNF{alpha} and possibly other mitogenic cytokines, and causes a rapid and sustained increase in hepatocyte proliferation in rodent liver.

 
Indeed, the data presented here provide strong evidence for a key role of NADPH OX in Kupffer cells as a source of oxidants induced by treatment with the peroxisome proliferator Wy-14,643. Furthermore, it is proposed that reactive oxygen species play a novel signaling role in the mechanism of action of this class of tumor promoters. Collectively, these data further support the role of Kupffer cells in the mechanism of increased cell proliferation due to this important class of suspected human carcinogens.


    FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported in part by Grant ES-04325 from the National Institute of Environmental Health Sciences. Back

2 To whom requests for reprints should be addressed, at Laboratory of Hepatobiology and Toxicology, Department of Pharmacology, CB #7365, University of North Carolina, Chapel Hill, NC 27599-7365. Phone: (919) 966-4745; Fax: (919) 966-1893; E-mail: thurman{at}med.unc.edu Back

3 The abbreviations used are: NF-{kappa}B, nuclear factor {kappa}B; Wy-14,643, 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio acetic acid; DPI, diphenyleneiodonium sulfate; PKC, protein kinase C; TNF{alpha}, tumor necrosis factor {alpha}; NADPH OX, NADPH oxidase; DEHP, di(2-ethylhexyl) phthalate; BrdUrd, 5-bromo-2'-deoxyuridine; LPS, lipopolysaccaride. Back

Received 12/28/99. Accepted 7/ 6/00.


    REFERENCES
 Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 

  1. IARC Working Group on Peroxisome Proliferation. Peroxisome Proliferation and its Role in Carcinogenesis. In: B. G. Lake and J. K. Reddy (eds.). Lyon, France: IARC, 1995.
  2. Rusyn I., Tsukamoto H., Thurman R. G. Wy-14,643 rapidly activates nuclear factor {kappa}B in Kupffer cells before hepatocytes. Carcinogenesis (Lond.), 19: 1217-1222, 1998.[Abstract/Free Full Text]
  3. Nilakantan V., Spear B. T., Glauert H. P. Liver-specific catalase expression in transgenic mice inhibits NF-{kappa}B activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate. Carcinogenesis (Lond.), 19: 631-637, 1998.[Abstract/Free Full Text]
  4. Ames B. N., Gold L. S. Too many rodent carcinogenesis mitogenesis increases mutagenesis. Science (Washington DC), 249: 970-971, 1990.[Free Full Text]
  5. Marsman D. S., Cattley R. C., Conway J. G., Popp J. A. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res., 48: 6739-6744, 1988.[Abstract/Free Full Text]
  6. Cattley R. C., Marsmann D. S., Popp J. A. Age related susceptibility to the carcinogenic effect of the peroxisome proliferator Wy-14,643 in rat liver. Carcinogenesis (Lond.), 12: 469-473, 1991.[Abstract/Free Full Text]
  7. Grasl-Kraupp B., Huber W., Taper H., Schulte-Hermann R. Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously. Cancer Res., 51: 666-671, 1991.[Abstract/Free Full Text]
  8. Marsman D. S., Popp J. A. Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643. Carcinogenesis (Lond.), 15: 111-117, 1994.[Abstract/Free Full Text]
  9. Rose M. L., Rusyn I., Bojes H. K., Germolec D. R., Luster M. I., Thurman R. G. Role of Kupffer cells in peroxisome proliferator-induced hepatocyte proliferation. Drug Metab. Rev., 31: 87-116, 1999.[Medline]
  10. Rose M. L., Germolec D. R., Schoonhoven R., Thurman R. G. Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators. Carcinogenesis (Lond.), 18: 1453-1456, 1997.[Abstract/Free Full Text]
  11. Bojes H. K., Germolec D. R., Simeonova P., Bruccoleri A., Luster M. I., Thurman R. G. Antibodies to tumor necrosis factor {alpha} prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643. Carcinogenesis (Lond.), 18: 669-674, 1997.[Abstract/Free Full Text]
  12. Rose M. L., Germolec D. R., Arteel G. E., Schoonhoven R., Thurman R. G. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator Wy-14,643. Chem. Res. Toxicol., 10: 1198-1204, 1997.[Medline]
  13. Rose M. L., Rivera C. A., Bradford B. U., Graves L. M., Cattley R. C., Schoonhoven R., Swenberg J. A., Thurman R. G. Kupffer cell oxidant production is central to the mechanism of peroxisome proliferators. Carcinogenesis (Lond.), 20: 27-33, 1999.[Abstract/Free Full Text]
  14. Moorhouse P. C., Grootveld M., Halliwell B., Quinlan J. G., Gutteridge J. M. C. Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett., 213: 23-28, 1987.[Medline]
  15. Jackson S. H., Gallin J. I., Holland S. M. The p47phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med., 182: 751-758, 1995.[Abstract/Free Full Text]
  16. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11: 1475-1489, 1983.[Abstract/Free Full Text]
  17. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.[Medline]
  18. Zabel U., Schreck R., Baeuerle P. A. DNA binding of purified transcription factor NF-{kappa}B. Affinity, specificity, Zn2+ dependence, and differential half-site recognition. J. Biol. Chem., 266: 252-260, 1991.[Abstract/Free Full Text]
  19. Baeuerle P. A., Baltimore D. A 65-{kappa}D subunit of active NF-{kappa}B is required for inhibition of NF-{kappa}B by I {kappa}B. Genes Dev., 3: 1689-1698, 1989.[Abstract/Free Full Text]
  20. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory ManualEd Cold Spring Harbor Laboratory 2. Cold Spring Harbor, NY 1989.
  21. Handler J. A., Bradford B. U., Glassman E. B., Forman D. T., Thurman R. G. Inhibition of catalase-dependent ethanol metabolism in alcohol dehydrogenase-deficient deermice by fructose. Biochem. J., 248: 415-421, 1987.[Medline]
  22. Smedsrod B., Pertoft H. Preparation of pure hepatocytes and reticuloendothelial cells in high yield from a single rat liver by means of Percoll centrifugation and selective adherence. J. Leukoc. Biol., 38: 213-230, 1985.[Abstract]
  23. Friedman S. L., Roll F. J. Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. Anal. Biochem., 161: 1233-1247, 1987.
  24. Inestrosa N. C., Bronfman M., Leighton F. Detection of peroxisomal fatty acyl-coenzyme A oxidase activity. Biochem. J., 182: 779-788, 1979.[Medline]
  25. Nash T. The colorimetric estimation of formaldehyde by means of the Hantzch reaction. Biochem. J., 55: 416-422, 1953.[Medline]
  26. Cross A. R., Jones O. T. G. The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Biochem. J., 237: 111-116, 1986.[Medline]
  27. Gatley S. J., Martin J. L. Some aspects of the pharmacology of diphenyleneiodonium, a bivalent iodine compound. Xenobiotica, 9: 539-546, 1979.[Medline]
  28. Cooper J. M., Petty R. K. H., Hayes D. J., Challiss R. A. J., Brosnan M. J., Shoubridge E. A., Radda G. K., Morgan-Hughes J. A., Clark J. B. An animal model of mitochondrial myopathy: a biochemical and physiological investigation of rats treated in vivo with the NADH-CoQ reductase inhibitor, diphenyleneiodonium. J. Neurol. Sci., 83: 335-347, 1988.[Medline]
  29. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem., 192: 245-261, 1990.[Medline]
  30. Beyer H. S., Theologides A. Tumor necrosis factor-{alpha} is a direct hepatocyte mitogen in the rat. Biochem. Mol. Biol. Int., 29: 1-4, 1993.[Medline]
  31. Bojes H. K., Rose M. L., Keller B. J., Germolec D., Simeonova P., Luster M. I., Thurman R. G. Mitogenic actions of peroxisome proliferators: involvement of protein kinase C and tumor necrosis factor {alpha}. Drug Metab. Rev., 29: 235-260, 1997.[Medline]
  32. Lazarow P. B. Rat liver peroxisomes catalyze the ß-oxidation of fatty acids. J. Biol. Chem., 253: 1522-1528, 1978.[Abstract/Free Full Text]
  33. Kasai H., Okada Y., Nishimura S., Rao M. S., Reddy J. K. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res., 49: 2603-2605, 1989.[Abstract/Free Full Text]
  34. Cattley R. C., DeLuca J., Elcombe C., Fenner-Crisp P., Lake B. G., Marsman D. S., Pastoor T. A., Popp J. A., Robinson D. E., Schwetz B., Tugwood J., Wahli W. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?. Regul. Toxicol. Pharmacol., 27: 47-60, 1998.
  35. Hegi M. E., Ulrich D., Sagelsdorff P., Richter C., Lutz W. K. No measurable increase in thymidine glycol or 8-hydroxydeoxyguanosine in liver DNA of rats treated with nafenopin or choline-devoid low-methionine diet. Mutat. Res., 238: 325-329, 1990.[Medline]
  36. Nicholls P., Schonbaum G. R. Catalases Ed. 2 Boyer P. D. eds. . The Enzymes, : 147-225, Academic Press, Inc. New York 1963.
  37. Handler J. A., Thurman R. G. Catalase-dependent ethanol oxidation in perfused rat liver. Requirement for fatty acid-stimulated H2 02 production by peroxisomes: Eur. J. Biochem., 176: 477-484, 1988.[Medline]
  38. Fan C. Y., Pan J., Usuda N., Yeldani A. V., Rao M. S., Reddy J. K. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor natural ligand metabolism. J. Biol. Chem., 273: 15639-15645, 1998.[Abstract/Free Full Text]
  39. Peters J. M., Rusyn I., Rose M. L., Gonzalez F. J., Thurman R. G. Peroxisome proliferator-activated receptor {alpha} is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis. Carcinogenesis (Lond.), 21: 823-826, 2000.[Abstract/Free Full Text]
  40. Bellavite P. The superoxide-forming enzymatic system of phagocytes. Free Radic. Biol. Med., 4: 225-261, 1988.[Medline]
  41. Livneh E., Fishman D. D. Linking protein kinase C to cell-cycle control. Eur. J. Biochem., 248: 1-9, 1997.[Medline]
  42. Majumdar S., Kane L. H., Rossi M. W., Volpp B. D., Nauseef W. M., Korchak H. M. Protein kinase C isotypes and signal-transduction in human neutrophils: selective substrate specificity of calcium-dependent ß-PKC and novel calcium-independent nPKC. Biochim. Biophys. Acta, 1176: 276-286, 1993.[Medline]



This article has been cited by other articles:


Home page
Toxicol SciHome page
C. G. Woods, A. M. Burns, B. U. Bradford, P. K. Ross, O. Kosyk, J. A. Swenberg, M. L. Cunningham, and I. Rusyn
WY-14,643 Induced Cell Proliferation and Oxidative Stress in Mouse Liver are Independent of NADPH Oxidase
Toxicol. Sci., August 1, 2007; 98(2): 366 - 374.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. A. Roberts, P. E. Ganey, C. Ju, L. M. Kamendulis, I. Rusyn, and J. E. Klaunig
Role of the Kupffer Cell in Mediating Hepatic Toxicity and Carcinogenesis
Toxicol. Sci., March 1, 2007; 96(1): 2 - 15.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
K. Bedard and K.-H. Krause
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Physiol Rev, January 1, 2007; 87(1): 245 - 313.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Teissier, A. Nohara, G. Chinetti, R. Paumelle, B. Cariou, J.-C. Fruchart, R. P. Brandes, A. Shah, and B. Staels
Peroxisome Proliferator-Activated Receptor {alpha} Induces NADPH Oxidase Activity in Macrophages, Leading to the Generation of LDL with PPAR-{alpha} Activation Properties
Circ. Res., December 10, 2004; 95(12): 1174 - 1182.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Rusyn, S. Asakura, B. Pachkowski, B. U. Bradford, M. F. Denissenko, J. M. Peters, S. M. Holland, J. K. Reddy, M. L. Cunningham, and J. A. Swenberg
Expression of Base Excision DNA Repair Genes Is a Sensitive Biomarker for in Vivo Detection of Chemical-induced Chronic Oxidative Stress: Identification of the Molecular Source of Radicals Responsible for DNA Damage by Peroxisome Proliferators
Cancer Res., February 1, 2004; 64(3): 1050 - 1057.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
R. C. Cattley
Peroxisome Proliferators and Receptor-Mediated Hepatic Carcinogenesis
Toxicol Pathol, February 1, 2004; 32(2_suppl): 6 - 11.
[Abstract] [PDF]


Home page
Cancer Res.Home page
D. Saha, K. R. Sekhar, C. Cao, J. D. Morrow, H. Choy, and M. L. Freeman
The Antiangiogenic Agent SU5416 Down-Regulates Phorbol Ester-Mediated Induction of Cyclooxygenase 2 Expression by Inhibiting Nicotinamide Adenine Dinucleotide Phosphate Oxidase Activity
Cancer Res., October 15, 2003; 63(20): 6920 - 6927.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. P. Anderson, C. S. Dunn, R. C. Cattley, and J.C. Corton
Hepatocellular proliferation in response to a peroxisome proliferator does not require TNF{alpha} signaling
Carcinogenesis, November 1, 2001; 22(11): 1843 - 1851.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. A. Koay, J. W. Christman, B. H. Segal, A. Venkatakrishnan, T. R. Blackwell, S. M. Holland, and T. S. Blackwell
Impaired Pulmonary NF-{kappa}B Activation in Response to Lipopolysaccharide in NADPH Oxidase-Deficient Mice
Infect. Immun., October 1, 2001; 69(10): 5991 - 5996.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
I. Rusyn, M. B. Kadiiska, A. Dikalova, H. Kono, M. Yin, K. Tsuchiya, R. P. Mason, J. M. Peters, F. J. Gonzalez, B. H. Segal, et al.
Phthalates Rapidly Increase Production of Reactive Oxygen Species in Vivo: Role of Kupffer Cells
Mol. Pharmacol., April 1, 2001; 59(4): 744 - 750.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rusyn, I.
Right arrow Articles by Thurman, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rusyn, I.
Right arrow Articles by Thurman, R. G.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online